…
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…, 28e
In forcesince 31 Dec 2020
Changed on 31 Dec 2020
The Agency and the Member States shall cooperate to continuously develop pharmacovigilance systems capable of achieving high standards of public health protection for all medicinal products, regardless of the routes of marketing authorisation, including the use of collaborative approaches, to maximise use of resources available within the Union.…
- 31 Dec 2020 – todayin force
- 2 Jul 2012 – 31 Dec 2020earlier wording
Versions are held from 26 Jan 2007; the article may be older.